NYSE· Wholesale-Drugs, Proprietaries & Druggists' Sundries· Inc. E9· CIK 0001180262

HLF

HERBALIFE LTD.
$12.56 ▲ +2.28%
Prev close $12.28
Market cap$1.3B
ConsensusBuy
12-mo target$17.00 (+35.4%)
▲ Bullish
Analyst conviction 8/10
Insider Selling Cluster (2 insiders)High Impact Filing (7/10) Healthcare & Medical Devices
Snapshot
The big-picture read on HLF right now — valuation, ownership and activity at a glance.
Market Cap
$1.3B
Cap Size
Small Cap
Analyst Consensus
Strong Buy (75%)
Insider Activity
$13.6K buy / $2.6M sell
Insider Net $
-$2.5M
Social Sentiment
70° Bullish
SEC Reports
6
Price chart 30d +3.2%
Daily candles (open–high–low–close) with volume. Green = up day, red = down day.
Vol
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Sep 18, 2026 short_volume
Short Volume: HLF — 58.6% short (0.3M / 0.5M)
Short: 299,424 | Exempt: 0 | TRF Vol: 510,609 | Short Ratio: 58.6% | Off-exchange volume (dark pool
Aug 31, 2026 SEC
Herbalife Ltd. announced that CEO Stephan Gratziani will transition out of his role effective October 31, 2026. No reaso
8-K — Impact 5/10
Aug 4, 2026 Insider
Lamberti Frank surrendered for taxes 1,710 shares
Chief Commercial Officer @ $12.80 ($21.9K)
Jun 4, 2026 Insider
L'Helias Sophie bought 1,200 shares
Director @ $11.31 ($13.6K)
May 21, 2026 SEC
Two senior HLF executives (Chief Commercial Officer and Chief Operating Officer) sold a combined $2.32M in open-market s
CLUSTER — Impact 5/10
May 19, 2026 Insider
Hicks Troy sold 10,000 shares
Chief Operating Officer @ $12.32 ($123.2K)
May 6, 2026 SEC
Herbalife reported Q1 2026 net sales of $1.317B (+7.8% YoY) and GAAP diluted EPS of $0.57, beating consensus of $0.55. F
8-K — Impact 7/10
Analyst ratings buy % +19.0%
How Wall Street rates the stock today, and the latest firm-by-firm actions.
Buy 75% rate it Buy or better · 8 analysts
Strong Buy 3 38% Buy 3 38% Hold 1 13% Sell 1 13% Strong Sell 0 0%
Recent analyst actions
DateFirmActionRatingFirm rating
Aug 7, 2026CitigroupMAINTAINBuy 55%
Apr 28, 2026RBC CapitalMAINTAINSector Perform 55%
Monthly consensus history
PeriodStr. BuyBuyHoldSellStr. SellBuy %Distribution
Sep 1, 20263311075%
Aug 1, 20263311075%
Jul 1, 20263311075%
Jun 1, 20263311075%
May 1, 20263321067%
Apr 1, 20263321067%
Mar 1, 20263321067%
Feb 1, 20263321067%
Price targets
Where 3 covering analysts think HLF trades over the next 12 months.
$17.00 +35.4% upside Strong Buy
Current$12.56 Low$9.00 Median$17.00 High$25.00 3 analysts
$9.00$25.00
Analyst rating None as of Oct 3, 2026
Social media sentiment mood -16.7%
Retail-investor mood aggregated across social media. 0° = very bearish, 100° = very bullish.
70°
Bullish
BearishNeutralBullish
6 mentions 4 bullish 0 bearish 2 neutral
Recent posts
Reports & filings
AI-scored summaries of recent SEC filings and press releases, with sentiment and impact.
6 SEC filing reports analyzed · 2 bullish, 2 bearish, 0 mixed, 2 neutral · avg impact 5.5/10.
Upcoming & catalyst events
Scheduled dates plus disclosed catalysts — earnings, dividends, enforcement, FDA and clinical-trial events. Colored dot = impact.
Sep 18, 2026
short_volume
Short Volume: HLF — 58.6% short (0.3M / 0.5M)
Short: 299,424 | Exempt: 0 | TRF Vol: 510,609 | Short Ratio: 58.6% | Off-exchange volume (dark pool + OTC)
Sep 9, 2026
short_volume
Short Volume: HLF — 62.3% short (0.3M / 0.5M)
Short: 341,865 | Exempt: 27 | TRF Vol: 548,562 | Short Ratio: 62.3% | Off-exchange volume (dark pool + OTC)
Sep 2, 2026
short_volume
Short Volume: HLF — 56.4% short (0.8M / 1.4M)
Short: 776,868 | Exempt: 155 | TRF Vol: 1,377,522 | Short Ratio: 56.4% | Off-exchange volume (dark pool + OTC)
Aug 17, 2026
short_volume
Short Volume: HLF — 56.3% short (0.3M / 0.5M)
Short: 285,832 | Exempt: 1,084 | TRF Vol: 508,036 | Short Ratio: 56.3% | Off-exchange volume (dark pool + OTC)
Aug 12, 2026
short_volume
Short Volume: HLF — 55.5% short (0.3M / 0.5M)
Short: 290,698 | Exempt: 905 | TRF Vol: 523,941 | Short Ratio: 55.5% | Off-exchange volume (dark pool + OTC)
Earnings estimates
Forecast earnings per share and revenue by period — and whether estimates are rising.
PeriodEPS Est.RangeGrowth30d RevUp/DnRevenue#
Current Q$0.62$0.59–$0.6423.4%-11.2%0↑ 2↓$1.3B2
Next Q$0.61$0.59–$0.6335.2%-11.8%0↑ 2↓$1.3B2
Current FY$2.37$2.33–$2.4011.6%-7.6%0↑ 2↓$5.3B2
Next FY$3.08$3.07–$3.0930.2%-2.4%1↑ 1↓$5.4B2
Current-quarter EPS estimate — revision history
WhenEPS estimateChange vs now
Current$0.617—
7d ago$0.617—
30d ago$0.695-0.078
60d ago$0.695-0.078
90d ago$0.695-0.078
Insider activity
Buying and selling by company executives and directors (SEC Form 4).
18 insiders, 47 transactions. Net -$2.5M — $13.6K bought, $2.6M sold.
DateInsiderTitleTypeSharesPriceValue
Aug 4, 2026Lamberti FrankChief Commercial OfficerTAX W/H1,710$12.80$21.9K
Jun 4, 2026L'Helias SophieDirectorBUY1,200$11.31$13.6K
May 19, 2026Hicks TroyChief Operating OfficerSELL10,000$12.32$123.2K
May 18, 2026Hicks TroyChief Operating OfficerTAX W/H58,064$12.59$731.0K
May 18, 2026Hicks TroyChief Operating OfficerEXERCISE65,789$9.58$630.3K
May 18, 2026Hicks TroyChief Operating OfficerSELL38,377$12.93$496.3K
May 18, 2026Hicks TroyChief Operating OfficerEXERCISE17,481$8.31$145.3K
May 18, 2026Hicks TroyChief Operating OfficerTAX W/H14,562$12.59$183.3K
May 12, 2026Lamberti FrankChief Commercial OfficerSELL134,982$13.50$1.8M
May 11, 2026Lamberti FrankChief Commercial OfficerSELL7,937$13.86$110.0K
Short interest & halts
FINRA semi-monthly short positions, Reg SHO threshold status, and recent trading halts for HLF.
Shares short
9,018,563
Settlement Sep 15, 2026
Change vs prior
+3.4%
Semi-monthly cycle
Days to cover
5.2
At avg daily volume
Of shares outstanding
≈8.6%
Estimate — not % of float
All HLF filing & press-release reports (6)